Redmile Group, LLC Portfolio Holdings
Redmile Group, LLC
- $1.28 Billion
- Q4 2024
Redmile Group, LLC has filed its 13F form on February 14, 2025 for Q4 2024 where it was disclosed a total value porftolio of $1.28 Billion distributed in 62 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Scholar Rock Holding Corp with a value of $197M, Krystal Biotech, Inc. with a value of $118M, Nurix Therapeutics, Inc. with a value of $79M, Amicus Therapeutics, Inc. with a value of $66.5M, and Replimune Group, Inc. with a value of $59.4M.
Examining the 13F form we can see an decrease of $251M in the current position value, from $1.53B to 1.28B.
Redmile Group, LLC is based out at San Francisco, CA
Below you can find more details about Redmile Group, LLC portfolio as well as his latest detailed transactions.